Bill Sponsor
House Bill 4733
115th Congress(2017-2018)
Opioids and STOP Pain Initiative Act
Introduced
Introduced
Introduced in House on Dec 21, 2017
Overview
Text
Introduced
Dec 21, 2017
Latest Action
Jan 3, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4733
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Vermont
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Connecticut
Democrat
Connecticut
Democrat
Maryland
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
New Hampshire
Democrat
New York
Republican
New York
Democrat
Pennsylvania
Democrat
Rhode Island
Democrat
Rhode Island
Republican
Tennessee
Democrat
Tennessee
Republican
West Virginia
Republican
West Virginia
Republican
West Virginia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Opioids and STOP Pain Initiative Act

This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:

  • understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
  • improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
  • supporting the Federal Pain Research Strategy.

NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

Text (1)
December 21, 2017
Actions (4)
01/03/2018
Referred to the Subcommittee on Health.
12/22/2017
Referred to the Subcommittee on Health.
12/21/2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
12/21/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:12 PM